跳至主要内容
临床试验/ACTRN12612000864820
ACTRN12612000864820尚未招募2 期

A short term study of safety and glycaemic outcomes in peritoneal dialysis patients with type 2 diabetes treated with metformin

Tilenka Thynne0 个研究点目标入组 6 人开始时间: 2012年8月15日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • (1)>18 years old
  • (2)Type 2 DM
  • (3)Peritoneal Dialysis treatment of chronic kidney disease
  • (4)Patients in whom metformin would be used if they had normal renal function

排除标准

  • (1)Any patient in whom metofrmin would not be used in the setting of normal renal function- moderate-severe heart failure, liver failure, alcohol abuse, major psychaitric disorder, acutely unwell or otherwise medically unstable.
  • (2)Unability or unwilling to measure own blood glucose concentrations via glucometer.
  • (3)Inability to provide written informed consent.

研究者

发起方
Tilenka Thynne

相似试验